RxDoctor Payments Data

Sherri Walker, DO

Family Medicine · Winchester, TNNPI 1265586259

Payments from drug & device makers

$514in general payments, 2019–2025

Across 29 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$177
  • Novo Nordisk$129
  • Amarin Pharma, Inc.$58
  • AstraZeneca$54
  • Novartis$22
  • Exact Sciences$18
  • plus $56 from 4 others

What the payments were for

  • Food & beverage$46991%
  • Education$459%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$514 in reported general payments places this provider in the 50th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$92,334
Medicare patients
181
Services billed
2,167

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin56$86,150
OzempicSemaglutide44$71,471
MounjaroTirzepatide54$68,163
EliquisApixaban96$64,563
TrulicityDulaglutide40$55,107
FarxigaDapagliflozin Propanediol41$40,759
Tresiba Flextouch U-200Insulin Degludec37$36,986
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog21$27,255
VraylarCariprazine Hcl17$25,768
JanuviaSitagliptin Phosphate20$21,747
VascepaIcosapent Ethyl27$17,258
XareltoRivaroxaban15$14,242
LinzessLinaclotide13$14,085
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$12,723
MyrbetriqMirabegron57$10,144

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$13$123,27094 claims
Novo NordiskOzempic$129$71,47144 claims
AstraZenecaFarxiga, Breztri Aerosphere$54$53,48260 claims
AbbVieVraylar, Linzess$177$39,85330 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Winchester

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →